TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24850615

Group type: EXPERIMENTAL
Intervention: Group-mediated cognitive behavioral (GMCB) intervention promoting home-based walking exercise.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving weekly on-site lectures unrelated to exercise.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (intervention and control) for WIQ distance score.
Number of subjects: 0
Study: 22219220

Group type: EXPERIMENTAL
Intervention: Surinabant 2.5 mg/day
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Surinabant 5 mg/day
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Surinabant 10 mg/day
Number of subjects: 810

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 810
Study: 20524401

Group type: EXPERIMENTAL
Intervention: OXA + 5‐FU/LV
Number of subjects: 2107

Group type: COMPARATOR
Intervention: IRI + 5‐FU/LV
Number of subjects: 2107
Study: 18485010

Group type: EXPERIMENTAL
Intervention: Higher number of cells (100,000,000) in Group H, n = 17
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lower number of cells (10,000,000) in Group L, n = 13
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no cell treatment) in Group C, n = 17
Number of subjects: 47
Study: 15769986

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (30 mug ethinyl estradiol and 150 mug levonorgestrel) for 9 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (sedentary controls)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Regularly menstruating athletes
Number of subjects: 36

Group type: COMPARATOR
Intervention: All groups (amenorrheic, regularly cycling, and sedentary controls)
Number of subjects: 36

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 36
Study: 11843507

Group type: EXPERIMENTAL
Intervention: Medtronic Freestyle root replacement
Number of subjects: 23

Group type: COMPARATOR
Intervention: Homograft aortic root replacement
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 10406153

Group type: EXPERIMENTAL
Intervention: Defibrotide (800-1600 mg daily)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study: 7500476

Group type: EXPERIMENTAL
Intervention: Robotic surgical arm
Number of subjects: 11

Group type: COMPARATOR
Intervention: Human surgical assistant
Number of subjects: 11
Study: 2210618

Group type: EXPERIMENTAL
Intervention: human growth hormone (hGH) alone
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: combination therapy with oxandrolone
Number of subjects: 71

Group type: COMPARATOR
Intervention: untreated control group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: subjects greater than or equal to 16 years of age
Number of subjects: 71
Study: 6108555

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg i.v.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ranitidine 50 mg i.v.
Number of subjects: 22
Study: 31006614

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet with a normocaloric hyperproteic formula (1035 kcal, 25% protein)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Weight loss greater than 15%
Number of subjects: 96
Study: 30014665

Group type: EXPERIMENTAL
Intervention: Mild moxibustion at Guanyuan (CV 4) and Sanyinjiao (SP 6), 20 minutes each time, once a day for 5 to 7 days before menstruation until menses, for 3 menstrual cycles.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waiting list group (no intervention)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy group (15 healthy individuals, no intervention)
Number of subjects: 30
Study: 26966237

Group type: EXPERIMENTAL
Intervention: Chimney stove intervention installed at birth
Number of subjects: 443

Group type: COMPARATOR
Intervention: Chimney stove intervention installed at 18 months
Number of subjects: 443
Study: 24937643

Group type: EXPERIMENTAL
Intervention: Bosentan (n = 40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bosentan and Placebo
Number of subjects: 60
Study: 22249235

Group type: EXPERIMENTAL
Intervention: Tube-shunt surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC)
Number of subjects: 0
Study: 20638139

Group type: EXPERIMENTAL
Intervention: Lip strengthening exercises using an oral screen for 16 min, 5 days/week for 16 weeks.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lip strengthening exercises using an oral screen.
Number of subjects: 8
Study: 17204315

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with birch pollen extract
Number of subjects: 9
Study: 17012870

Group type: EXPERIMENTAL
Intervention: Hexavalent combined vaccine (DTaP‐IPV‐PRP approximately T‐HBs, HEXAVAC)
Number of subjects: 1028
Study: 12182380

Group type: EXPERIMENTAL
Intervention: PncD (diphtheria toxoid)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: PncT (tetanus protein)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: PncD
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: PncT
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 160
Study: 10467325

Group type: EXPERIMENTAL
Intervention: CD34+ cell selected autologous PBSCT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (unselected autologous PBSCT)
Number of subjects: 30
Study: 8617415

Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1965289

Group type: EXPERIMENTAL
Intervention: Dentifrice containing 1.30% soluble pyrophosphate and 1.50% copolymer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo dentifrice (no anticalculus ingredient)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dentifrice containing 1.30% soluble pyrophosphate without copolymer
Number of subjects: 0
Study: 6769032

Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1558
Study: 29677190

Group type: EXPERIMENTAL
Intervention: Haplotype of rs9930506, rs9930501, and rs9932754 (GGT) in the FTO gene
Number of subjects: 237

Group type: COMPARATOR
Intervention: GGC genotypes
Number of subjects: 237

Group type: COMPARATOR
Intervention: AAT genotypes
Number of subjects: 237
Study: 27712671

Group type: EXPERIMENTAL
Intervention: Needs-based exclusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statistical exclusion
Number of subjects: 0
Study: 24765680

Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study: 22512984

Group type: EXPERIMENTAL
Intervention: Baseline assessment of visual acuity for fluid only
Number of subjects: 1185
Study: 20541889

Group type: EXPERIMENTAL
Intervention: Mini-midvastus approach
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard approach
Number of subjects: 27
Study: 18447898

Group type: EXPERIMENTAL
Intervention: Static night splinting for six months worn at night time only, in addition to hand therapy.
Number of subjects: 102

Group type: COMPARATOR
Intervention: Hand therapy only (non-splint group).
Number of subjects: 102
Study: 15812372

Group type: EXPERIMENTAL
Intervention: Anterior MI patients
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Inferior MI patients
Number of subjects: 38
Study: 12593525

Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) 800 microg day(‐1) suspension for nebulization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 750 microg day(‐1) given by nebulization
Number of subjects: 0
Study: 10754623

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ondansetron 25 microg/kg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ondansetron 50 microg/kg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ondansetron 75 microg/kg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ondansetron 100 microg/kg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ondansetron 150 microg/kg
Number of subjects: 180
Study: 8757525

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: G-CSF and GM-CSF
Number of subjects: 24
Study: 1287848

Group type: EXPERIMENTAL
Intervention: UFN (Unreamed Femoral Nailing)
Number of subjects: 16

Group type: COMPARATOR
Intervention: AFN (Reamed Femoral Nailing)
Number of subjects: 16
Study: 6389558

Group type: EXPERIMENTAL
Intervention: Above-elbow cast-brace with the forearm in supination
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Below-elbow cast-brace
Number of subjects: 243

Group type: COMPARATOR
Intervention: Conventional Colles' type plaster
Number of subjects: 243
Study: 31353989

Group type: EXPERIMENTAL
Intervention: nalbuphine 0.07 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: dexmedetomidine 0.5 µg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 120
Study: 29079057

Group type: EXPERIMENTAL
Intervention: Cold saline irrigation (20 mL at 2.5°C for 5 minutes)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Room temperature saline irrigation (control group)
Number of subjects: 210
Study: 29231452

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion based on meridian differentiation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study: 1444945

Group type: EXPERIMENTAL
Intervention: EMLA 5% Cream
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xylocaine 5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NUM (benzocaine 15%, amethocaine 1.7%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22876438

Group type: EXPERIMENTAL
Intervention: Weining granules
Number of subjects: 120

Group type: COMPARATOR
Intervention: Weifuchun tablets
Number of subjects: 120
Study: 20398351

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 gram by intravenous injection)
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15000
Study: 18548827

Group type: COMPARATOR
Intervention: Mirtazapine 7.5, 15, 30, and/or 45 mg (Study 1)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mirtazapine 15 mg (Study 2)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mirtazapine (both studies)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mirtazapine 15 mg + Compound CD0012 (Study 2)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (both studies)
Number of subjects: 85
Study: 16217274

Group type: EXPERIMENTAL
Intervention: Prophylactic radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors and 4-hydroxytamoxifen
Number of subjects: 0
Study: 12455332

Group type: EXPERIMENTAL
Intervention: No time pressure (no response deadline)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Time pressure (response deadline of 5 s)
Number of subjects: 399
Study: 10378706

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nifedipine (20 mg daily)
Number of subjects: 40
Study: 8607678

Group type: EXPERIMENTAL
Intervention: Steel bands (4 to 6 bands)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard stainless steel wires (6 to 8 wires)
Number of subjects: 48
Study: 1960301

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg/day)
Number of subjects: 796
Study: 6316518

Group type: EXPERIMENTAL
Intervention: Biostim (8 mg/day) for 15 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study: 30971316

Group type: EXPERIMENTAL
Intervention: F-100 intake
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Tuberculosis infection
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Provision of special medication (IV fluid, IV antibiotic, and blood transfusion)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Overall recovery rate
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Mortality rate
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Mean weight gain rate
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Incidence density rate of recovery
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Median time of recovery
Number of subjects: 420
Study: 29436868

Group type: EXPERIMENTAL
Intervention: Oxygen therapy (10 l/min)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 160
Study: 26471114

Group type: EXPERIMENTAL
Intervention: High frequency (150 Hz) insular stimulation for 10 min before pain testing
Number of subjects: 6
Study: 24908627

Group type: EXPERIMENTAL
Intervention: Inadine dressing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acticoat dressing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activon Tulle dressing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline soaked gauze control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma cytokines (IL‐4, TNFα, MCP‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCR array analysis
Number of subjects: 0
Study: 22243494

Group type: EXPERIMENTAL
Intervention: Warfarin + Anacetrapib
Number of subjects: 12
Study: 19640014

Group type: EXPERIMENTAL
Intervention: Schema-Focused Therapy (SFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transference-Focused Psychotherapy (TFP)
Number of subjects: 0
Study: 22983102

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (sodium chloride)
Number of subjects: 50
Study: 15815895

Group type: EXPERIMENTAL
Intervention: Cisatracurium infusion
Number of subjects: 37

Group type: COMPARATOR
Intervention: Vecuronium infusion
Number of subjects: 37
Study: 12444178

Group type: EXPERIMENTAL
Intervention: HPV‐16 virus‐like‐particle vaccine (40 microg per dose)
Number of subjects: 2392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2392
Study: 10349300

Group type: EXPERIMENTAL
Intervention: 600 mg/day of ethylcysteine (EC) for 3 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: 600 mg/day of Vitamin E (Vit. E) for 3 months
Number of subjects: 10
Study: 8953630

Group type: EXPERIMENTAL
Intervention: Timed 5 km cycle ergometer ride
Number of subjects: 52
Study: 1941403

Group type: COMPARATOR
Intervention: Standard premature formula (1.34 microgram of Se/dl)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Selenium-supplemented formula (2.03 micrograms of Se/dl)
Number of subjects: 20
Study: 7173046

Group type: EXPERIMENTAL
Intervention: Codeine sulfate 60 mg po
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Codeine phosphate 60 mg im
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 22
Study: 29399865

Group type: EXPERIMENTAL
Intervention: 5000 IU cholecalciferol daily for 5 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 26879007

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 6% 130/0.4 (Volulyte)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gelatin (Geloplasma)
Number of subjects: 40
Study: 25147079

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.2-0.4 mg daily)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 23881862

Group type: EXPERIMENTAL
Intervention: Conventional programming with a ventricular tachycardia zone of 170 to 199 bpm (arm A)
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: High-rate cutoff with a ventricular tachycardia zone ≥200 bpm (arm B)
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: 60-second-delayed therapy (arm C)
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Inappropriate therapy in diabetic patients
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Appropriate therapy in diabetic patients
Number of subjects: 1483
Study: 20827448

Group type: EXPERIMENTAL
Intervention: IR‐A irradiation treatment
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo (visible, but not IR irradiation)
Number of subjects: 207

Group type: COMPARATOR
Intervention: No irradiation
Number of subjects: 207
Study: 18005966

Group type: EXPERIMENTAL
Intervention: Vitamins C and E supplementation (343 mg and 84 mg respectively)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Vitamins C and E supplementation
Number of subjects: 34
Study: 16012275

Group type: EXPERIMENTAL
Intervention: Quetiapine dosage escalation to 400 mg/d in 5 days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Quetiapine dosage escalation to 400 mg/d in 3 days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Quetiapine dosage escalation to 400 mg/d in 2 days
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 14616184

Group type: EXPERIMENTAL
Intervention: Modified Reasons for Smoking Scale (MRSS)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Time to first cigarette after awakening
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Habit/automatism score
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Number of cigarettes smoked per day
Number of subjects: 330
Study: 9892331

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin (500 mg twice daily)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Intravenous ciprofloxacin (200 mg twice daily)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 139

Group type: COMPARATOR
Intervention: Intravenous ciprofloxacin
Number of subjects: 139
Study: 8721128

Group type: EXPERIMENTAL
Intervention: PGE1
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control
Number of subjects: 26
Study: 1816434

Group type: EXPERIMENTAL
Intervention: Isodinit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monizid
Number of subjects: 0
Study: 6109047

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet containing leguminous fibre (HL) for 6 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard low carbohydrate diet (LC) for 6 weeks
Number of subjects: 27
Study: 30110179

Group type: EXPERIMENTAL
Intervention: Economic intervention plus family coaching group (TU+)
Number of subjects: 360
Study: 29433500

Group type: EXPERIMENTAL
Intervention: Local neck treatment
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Local treatment plus tailored sensorimotor exercises
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Local treatment plus balance exercises
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Local treatment plus sensorimotor and balance exercises
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 168
Study: 26708700

Group type: EXPERIMENTAL
Intervention: NNS beverages
Number of subjects: 303

Group type: COMPARATOR
Intervention: Water
Number of subjects: 303
Study: 24429539

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention consisting of print materials and 4 telephone-counseling calls delivered over 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Print information-only control group
Number of subjects: 0
Study: 22353925

Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation (PS)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Food supplementation (FS)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: PS + FS
Number of subjects: 507

Group type: COMPARATOR
Intervention: Clinic-control
Number of subjects: 507

Group type: COMPARATOR
Intervention: Hospital-control
Number of subjects: 507
Study: 20647478

Group type: EXPERIMENTAL
Intervention: Neratinib (240 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Neratinib (240 mg) plus ketoconazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo plus ketoconazole
Number of subjects: 60
Study: 17582439

Group type: EXPERIMENTAL
Intervention: Intraspinal injections of autologous mesenchymal stem cells (MSCs) at the thoracic level
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intraspinal injections of autologous mesenchymal stem cells (MSCs)
Number of subjects: 9
Study: 15729064

Group type: EXPERIMENTAL
Intervention: Selective digestive decontamination (SDD)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 11917904

Group type: EXPERIMENTAL
Intervention: Dihydrotestosterone (DHT; 70 mg/day) for 3 months
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo gel for 3 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Age-related differences in muscle strength
Number of subjects: 66
Study: 9623225

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 7614103

Group type: EXPERIMENTAL
Intervention: Cisapride 30 mg daily
Number of subjects: 203

Group type: COMPARATOR
Intervention: Ranitidine 300 mg daily
Number of subjects: 203
Study: 1978771

Group type: EXPERIMENTAL
Intervention: Clindamycin, 600 mg intravenously every 6 hours, followed by oral clindamycin, 300 mg every 6 hours for a minimum of 4 weeks.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Penicillin G, 2 million U every 4 hours for no less than 8 days, followed by oral penicillin V, 750 mg every 6 hours for a minimum of 4 weeks.
Number of subjects: 37
Study: 850696

Group type: EXPERIMENTAL
Intervention: Passive stretch
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contraction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 31116996

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) + photodynamic therapy (PDT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 36